
In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control
Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps using algorithms to manage insulin. Learn more about Breakthrough T1D's funding of groundbreaking AP technology research.

Breakthrough T1D-Funded Researchers Reprogram Human Alpha Cells to Produce Insulin
Human cells, including pancreatic islet cells, are more adaptive than previously believed. Led by Dr. Pedro Herrera at the University of Geneva, Breakthrough T1D-funded researchers demonstrated that transplanted alpha and gamma cells could produce insulin and reverse diabetes in mice.

Multiple Benefits of Screening For Beta Cell Autoimmunity in Children
Learn more about Breakthrough T1D’s prevention research and the benefits of early detection for type 1 diabetes (T1D).

Stem Cells to Beta Cells for Insulin Therapy: One Step Forward by Breakthrough T1D-Funded Researchers
Scientists have made a significant advancement in beta cell replacement research, potentially eliminating the need for insulin therapy for people with type 1 diabetes (T1D). This novel approach could pave the way for effective beta cell replacement therapies, offering hope for those with T1D.

ATTD Conference Brings Together Top Minds in Diabetes Research
Join diabetes researchers from around the world at the annual Advanced Technologies & Treatments for Diabetes (ATTD) conference. Breakthrough T1D-funded research will be featured, with 23 funded researchers presenting.

FDA Approval Means More Choices for our T1D Community
The FDA approves the first interoperable insulin pump, the t:slim X2™ by Tandem Diabetes Care.

Video Preview: World-Renowned Researchers Gather at the nPOD Annual Meeting
At the Network for Pancreatic Organ Donors with Diabetes (nPOD) Meeting—its 11th annual and taking place February 19-22—more than 215 people are attending, including some of the most world-renowned diabetes investigators. Many of the latest advances will be discussed—using nPOD samples—to accelerate breakthroughs to cure, prevent, and treat type 1 diabetes (T1D) and its complications. […]

T1D Diagnosis? Gut Bacteria May Hold the Clue
Over the past 50 years, type 1 diabetes (T1D) has increased significantly in many developed countries around the world. There is a genetic component, but genes cannot explain the recent increase in T1D rates, and data suggests that changes in our modern environment have increased the risk for the disease. The human digestive tract hosts […]

Learning to Speak Type 1 Diabetes
Consider the following: The endo says you’re in DKA with an A1c of 11 and that there’s a chance you’re still in the honeymoon phase. Wait, what? If you’re new to type 1 diabetes (T1D), that probably doesn’t make a whole lot of sense. But these terms are ones that people with T1D have […]

SGLT Inhibition: It’s Not Just for Type 2 Anymore
Can a drug long-used for type 2 diabetes, also help those with T1D? The European body that approves medicines for human-use thinks so.